At Amneal, we are committed to people living with Parkinson’s disease. We believe that every dose and every detail makes a difference—and that together, with patients, care partners, healthcare providers, and advocacy, we can achieve so much more.
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
INSIGHTEC is a fast-growing medical technology innovator transforming patient lives through incisionless surgery. For hundreds of years, surgeons have been cutting away diseased tissue. With INSIGHTEC’s focused ultrasound technology guided by MR imaging, sound waves can precisely treat tissue deep in the brain, with no incisions. The surgeon is equipped with a workstation, keyboard and mouse – no scalpel and no cutting. The company’s award-winning Exablate Neuro™ is used by neurosurgeons to perform the treatment to deliver immediate and durable tremor relief for essential tremor and tremor dominant Parkinson’s disease patients. INSIGHTEC is headquartered in Haifa, Israel, and Miami.